Related Experiment Video
Updated: Jul 14, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity
Sachiko Yokoo1, Atsushi Yonezawa, Satohiro Masuda
1Department of Pharmacy, Kyoto University Hospital, Faculty of Medicine, Kyoto 606-8507, Japan.
Abstract:
The mechanism of severe nephrotoxicity caused by cisplatin, but not carboplatin, oxaliplatin, and nedaplatin, is not fully understood. The renal accumulation and subsequent nephrotoxicity of platinum agents were examined in rats. Among these four drugs, only cisplatin induced nephrotoxicity at 2 days after its intraperitoneal administration. The urinary activity of N-acetyl-beta-D-glucosaminidase and expression of kidney injury molecule-1 mRNA and osteopontin were markedly enhanced in the cisplatin-treated rats. Although some markers were affected in the rats administered nedaplatin, only minor histological change was observed. The renal accumulation of cisplatin was much greater than that of the other drugs. In the in vitro study, the cellular accumulation of cisplatin and oxaliplatin was stimulated by the expression of rat (r) OCT2. Oxaliplatin was also transported by rOCT3. A luminal H(+)/organic cation antiporter, rMATE1 (multidrug and toxin extrusion) as well as human (h) MATE1 and hMATE2-K, stimulated the H(+)-gradient-dependent antiport of oxaliplatin, but not of cisplatin. Carboplatin and nedaplatin were not transported by these transporters. In conclusion, the nephrotoxicity of platinum agents was closely associated with their renal accumulation, which is determined by the substrate specificity of the OCT and MATE families.
Insights
Cisplatin causes severe kidney damage due to higher renal accumulation, unlike other platinum drugs. This nephrotoxicity is linked to specific transporter interactions, explaining differences in platinum-based chemotherapy side effects.
Area of Science:
- Pharmacology
- Nephrology
- Toxicology
Background:
- Severe nephrotoxicity is a significant side effect of platinum-based chemotherapy agents.
- The precise mechanisms underlying differential nephrotoxicity among platinum drugs like cisplatin, carboplatin, oxaliplatin, and nedaplatin remain unclear.
Purpose of the Study:
- To investigate the renal accumulation and nephrotoxicity of four platinum agents in a rat model.
- To elucidate the role of organic cation transporters (OCTs) and multidrug and toxin extrusion (MATE) transporters in platinum-induced nephrotoxicity.
Main Methods:
- Rats were administered cisplatin, carboplatin, oxaliplatin, or nedaplatin intraperitoneally.
- Renal accumulation and markers of kidney injury (NAG, KIM-1, osteopontin) were assessed.
- In vitro studies using cell lines expressing rat and human OCT and MATE transporters were performed to evaluate drug transport.
Main Results:
- Cisplatin induced significant nephrotoxicity and higher renal accumulation compared to other platinum agents.
- Urinary NAG activity and kidney injury markers were elevated in cisplatin-treated rats.
- In vitro, cisplatin and oxaliplatin cellular uptake was mediated by OCT2, while oxaliplatin was also transported by OCT3, MATE1, MATE2-K, but cisplatin was not transported by MATEs.
Conclusions:
- Platinum agent nephrotoxicity is closely correlated with their renal accumulation.
- The substrate specificity of OCT and MATE transporter families significantly influences platinum drug accumulation and subsequent nephrotoxicity.
Related Concept Videos
Drug Elimination by Renal Route: Tubular Secretion
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pore Transport and Ion-Pair Transport
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Renal Drug Excretion: Tubular Secretion
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
